Veracyte, Inc.
VCYT
Hisse Senetlerindeki Sıralama
#4358
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Hisse Fiyatı
$44.93
Piyasa Değeri
$3.61B
Değişim (1 gün)
2.57%
Değişim (1 yıl)
22.59%
Ülke
US
Ticaret Veracyte, Inc. (VCYT)
Kategori
Healthcare
Veracyte, Inc. (VCYT) için kazanç
Jun 2026 itibarıyla kazanç TTM: $108.94M
Veracyte, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı $108.94M'dir. 2023 yılında şirket $-76.61M kazanç elde etti, bu 2022 yılındaki $-36.43M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Veracyte, Inc. için kazanç geçmişi 2011 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2026 (TTM) | $108.94M | 323.17% |
| 2024 | $25.74M | -133.60% |
| 2023 | $-76.61M | 110.32% |
| 2022 | $-36.43M | -55.39% |
| 2021 | $-81.65M | 133.89% |
| 2020 | $-34.91M | 177.08% |
| 2019 | $-12.60M | -45.22% |
| 2018 | $-23.00M | -25.82% |
| 2017 | $-31.00M | -1.13% |
| 2016 | $-31.36M | -6.96% |
| 2015 | $-33.70M | 14.74% |
| 2014 | $-29.37M | 14.83% |
| 2013 | $-25.58M | 37.17% |
| 2012 | $-18.65M | 29.10% |
| 2011 | $-14.45M | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| $7.61B | 6,884.58% |
US
|
|
| $4.76B | 4,271.21% |
US
|
|
| $-252.70M | -331.96% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 1,421.94% |
US
|
